CAS No.:520-18-3
Name: Kaempferol
Details Introduction
TOXICITY DATA with REFERENCE:
1. |
mma-sat 166 nmol/plate |
MUREAV Mutation Research. 54 (1978),297. | ||
2. |
mnt-mus-ipr 200 mg/kg |
MUREAV Mutation Research. 89 (1981),69. |
RTECS: LK9275200
Consensus Reports:IARC Cancer Review: Group 3 IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 7 , 1987,p. 56.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Animal Inadequate Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 31 , 1983,p. 171.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) .
SAFETY PROFILE:
Questionable carcinogen. Mutation data reported. When heated to decomposition it emits acrid smoke and fumes.
Hazard Codes: Xi
Risk Statements: 36/37/38
Safety Statements: 26-36
F: 8-10-23
Related Searches

Related Suppliers
- Shanghai Haoyuan Chemexpress Co., Ltd.
- Nanjing Chemlin Chemical Co., Ltd.
- Xi'an Jiangxing Biotechnique Co., Ltd.
- QVENTAS
- SINO GREAT ENTERPRISE LTD.
- cfm Oskar Tropitzsch
- Aktin Chemicals, Inc.
- Chengdu Cogon Bio-tech Co., Ltd.
- Nanjing Zelang Medical Technology Co. Ltd
- Shanghai Forever Biotech Co., Ltd.
- ORCHID CHEMICAL SUPPLIES LTD
- Shannxi Extract Supplier
- Zhejiang Chemline International Co., Ltd.
- Zhengzhou Tongguang Chemical Science C,.Ltd
- Baoji Guokang Bio-Technology Co.,Ltd
- Yangling Dongke Maidisen Pharmaceutical Co, Ltd
- XI'AN CHUKANG BIOTECHNOLOGY CO.,LTD
- Xi'an Costrong Pharmaceutical Co., Ltd.
- Shaanxi Huike Botanical Development Co.,Ltd.
- Shaanxi King Stone Enterprise Company Limited
Other Product
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (4S,6R)-6-{2-[(2-hydroxy-ethyl)-(4-methoxy-benzenesulfonyl)-amino]-ethoxy}-4-isopropyl-5,6-dihydro-4H-pyran-2-carboxylic acid allyl ester
- [1,4'-Bipiperidine]-1'-carboxylic acid, 4-(1H-indol-7-yl)-, ethyl ester
- 1,3,5-Tris(4-acetamidophenyl)penta-1,5-dione
- 1,5-Bis(3-aminophenyl)-3-(4-N,N-di-methylaminophenyl)penta-1,5-dione
- 1,5-Bis(4-acetamidophenyl)-3-phenylpenta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-(4-acetamido-phenyl)penta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-phenylpenta-1,5-dione